NCT01113671
- Conditions
- Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Laboratory of Vascular Medicine, Technion Faculty of Medicine Haifa, Israel
Clinical trial condition
Diabetes Mellitus Type 2
Explore clinical trials studying Diabetes Mellitus Type 2. Study availability and eligibility vary by location and protocol.
264 public trials
30 recruiting studies
Diabetes Mellitus Type 2 trial results
Completed
Exercise and Acarbose in Type 2 Diabetes
NCT01244971
- Conditions
- Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Enheten för Metabol Kontroll, Endokrinkliniken, Karolinska University Hospital Stockholm, Stockholm County, Sweden
NCT00233649
- Conditions
- Crestor, Rosuvastatin, Diabetes Mellitus, Diabetes Mellitus Type 2, +7 more
- Locations
-
- Research Site 's Gravenmoer, Netherlands
- Research Site 's-Hertogenbosch, Netherlands
- Research Site Aalten, Netherlands
- Research Site Alkmaar, Netherlands
NCT00807976
- Conditions
- Autonomic Nervous System Diseases, Cardiovascular Diseases, Diabetes Mellitus, +13 more
- Locations
-
- Diabetes centre, Isala Clinics Zwolle, Netherlands
NCT00354939
- Conditions
- Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
- Locations
-
Not specified
NCT00403091
- Conditions
- Cardiovascular Diseases, Diabetes Mellitus, Diabetes Mellitus Type 2, +10 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- University of Alabama Tuscaloosa, Alabama, United States
NCT01154413
- Conditions
- Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
- Locations
-
Not specified
Completed
OatMeal and Insulin Resistance: OMA-IR
NCT00401453
- Conditions
- Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +6 more
- Locations
-
- Fifth Medical Clinic Mannheim, Baden-Wurttemberg, Germany
NCT00272012
- Conditions
- Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Sanofi-Aventis Berlin, Germany
NCT00494013
- Conditions
- Diabetes Mellitus, Diabetes Mellitus Type 2, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hueytown, Alabama, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Litchfield Park, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Phoenix, Arizona, United States
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Buena Park, California, United States